| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DEXCOM INC | 176,038 | 14,418,000 | 0.44% | ||
| 52 | MCKESSON CORP | 72,627 | 14,324,000 | 0.44% | ||
| 53 | KURA ONCOLOGY INC | 1,494,169 | 12,551,000 | 0.38% | ||
| 54 | CLOVIS ONCOLOGY INC | 325,100 | 11,379,000 | 0.35% | Call | |
| 55 | MYOKARDIA INC | 698,694 | 10,243,000 | 0.31% | ||
| 56 | OREXIGEN THERAPEUTICS INC | 16,788,000 | 10,034,000 | 0.30% | PRN | |
| 57 | AMAG PHARMACEUTICALS INC | 282,420 | 8,526,000 | 0.26% | ||
| 58 | DIMENSION THERAPEUTICS INC | 815,359 | 8,385,000 | 0.25% | ||
| 59 | GILEAD SCIENCES INC | 66,187 | 6,697,000 | 0.20% | ||
| 60 | JUNO THERAPEUTICS INC COM | 150,684 | 6,626,000 | 0.20% | ||
| 61 | CLOVIS ONCOLOGY INC | 4,637,000 | 3,988,000 | 0.12% | PRN | |
| 62 | COHERUS BIOSCIENCES INC COM | 172,638 | 3,964,000 | 0.12% | ||
| 63 | ATLASSIAN CORP PLC | 98,357 | 2,959,000 | 0.09% | ||
| 64 | PENUMBRA INC COM | 46,531 | 2,504,000 | 0.08% | ||
| 65 | SAGE THERAPEUTICS INC | 40,850 | 2,382,000 | 0.07% | ||
| 66 | REGENXBIO INC COM | 119,092 | 1,977,000 | 0.06% | ||
| 67 | MAXLINEAR INC COM | 81,443 | 1,200,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-082684, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
